The new document focuses on the influence of PBMs over the market for specialty generic drugs for illnesses like cancer, ...
Agency commissioners voted unanimously on Tuesday to publish the report, which makes similar allegations against the ...
Pharmacies like Snyders rely on reimbursements to make ends meet. When his business dispenses prescriptions, the repayment ...
On Tuesday, the Federal Trade Commission released its second interim staff report on prescription drug middlemen. The report ...
From 2017 to 2022, the companies marked up prices at their pharmacies by hundreds or thousands of percent, netting them $7.3 ...
CVS Caremark Rx blasted the findings for cherry picking certain drugs in an effort to push what it called an 'anti-PBM' ...